BD 231673 - Sensi-Disc Cefpodoxime, 10 mcg Antimicrobial Susceptibility Testing Discs, 50/BX
The BD 231673 - BD Sensi-Disc Cefpodoxime is a high-quality antimicrobial susceptibility testing disc used to determine bacterial resistance or sensitivity to the antibiotic cefpodoxime. Each disc contains 10 micrograms (mcg) of cefpodoxime and is manufactured by Becton Dickinson (BD) under strict quality control standards to ensure consistent potency, diffusion, and performance. Designed for use in standardized disc diffusion assays such as the Kirby-Bauer method, these discs help clinicians and microbiologists evaluate the effectiveness of cefpodoxime against bacterial isolates from clinical specimens.
As part of BDs trusted Sensi-Disc product line, the BD 231673 discs deliver accurate, reproducible results in antimicrobial susceptibility testing (AST), enabling laboratories to guide effective antibiotic therapy decisions and support antimicrobial stewardship initiatives.
Key Benefits
The BD Sensi-Disc Cefpodoxime discs provide dependable, standardized antibiotic diffusion results that conform to CLSI (Clinical and Laboratory Standards Institute) guidelines. Each disc is impregnated with a uniform antibiotic concentration, ensuring consistent zone diameters and reproducibility across tests. The discs are packaged in moisture-resistant cartridges to preserve potency and shelf life. BDs manufacturing precision ensures reliable batch-to-batch consistency, supporting high-quality diagnostic performance in clinical, pharmaceutical, and research laboratories. The discs facilitate rapid and cost-effective evaluation of cefpodoxime susceptibility in both Gram-positive and Gram-negative bacteria.
Compatibility and Applications
The BD 231673 Cefpodoxime Sensi-Disc is compatible with standard susceptibility testing media such as BD Mueller-Hinton Agar and complies with CLSI M100 performance standards. It is suitable for use with both manual and automated susceptibility testing systems that support disc diffusion methods. Typical applications include:
- Clinical microbiology labs performing routine AST on pathogens such as Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, and Streptococcus pneumoniae.
- Pharmaceutical and academic research facilities validating antibiotic efficacy studies.
- Public health and reference laboratories monitoring antimicrobial resistance trends.
These discs are essential for determining appropriate antibiotic regimens and monitoring resistance development in clinical and epidemiological settings.
Usage Guidelines
Use BD Sensi-Disc Cefpodoxime discs according to CLSI-approved protocols for the Kirby-Bauer disc diffusion method. Prepare a standardized bacterial inoculum equivalent to a 0.5 McFarland standard and evenly streak it over the surface of Mueller-Hinton Agar. Place the cefpodoxime 10 mcg disc onto the inoculated surface using sterile forceps or a disc dispenser, ensuring even contact. Incubate plates at 35 2C for 1618 hours (aerobic conditions) or according to organism-specific requirements. After incubation, measure the diameter of the inhibition zone and interpret susceptibility results using CLSI interpretive criteria. Always store discs in their original cartridge at 28C and avoid repeated exposure to ambient air or humidity.
Certifications, Safety Standards, and Regulatory Approvals
The BD Sensi-Disc Cefpodoxime discs are manufactured in accordance with ISO 13485:2016 and ISO 9001 quality management standards. The product complies with FDA and CE regulatory requirements for in vitro diagnostic (IVD) medical devices. Each lot is quality-assured for potency, diffusion characteristics, and sterility. BDs manufacturing facilities operate under Good Manufacturing Practices (GMP), ensuring consistent, reliable, and validated product performance in clinical laboratories worldwide.
Comparison with Competitor Products
Compared to other antibiotic susceptibility discs on the market, the BD Sensi-Disc Cefpodoxime provides superior consistency, quality control, and reliability. Competing brands may exhibit variable antibiotic release or inconsistent disc potency, leading to inaccurate results. BDs proprietary manufacturing process ensures uniform antibiotic distribution and precise calibration of each disc, resulting in reproducible inhibition zone measurements. In addition, BDs moisture-resistant cartridges and desiccant packaging maintain long-term disc stability, minimizing potency loss during storage or handling.
Typical User Profile and Application Scenarios
This product is used by clinical microbiologists, laboratory technicians, and researchers performing antimicrobial susceptibility testing in hospital, reference, or industrial laboratories. It is particularly suited for facilities following CLSI or EUCAST standards for AST procedures. Common applications include routine testing of clinical isolates, quality assurance programs in diagnostic laboratories, and research on emerging antibiotic resistance mechanisms. The BD Sensi-Disc Cefpodoxime helps clinicians identify resistant strains and optimize antibiotic therapy for patients with bacterial infections.
Best Practices for Use and Maintenance
Store BD Sensi-Disc cartridges at 28C and protect from moisture, light, and temperature fluctuations. Allow discs to equilibrate to room temperature for 30 minutes before opening the cartridge. Avoid prolonged exposure to open air and close the cartridge immediately after use to preserve potency. Discs should be handled with sterile forceps or a disc dispenser to prevent contamination. Perform periodic quality control testing using reference strains recommended by CLSI (e.g., Escherichia coli ATCC 25922) to verify performance consistency. Dispose of used discs and culture materials according to institutional biohazard waste guidelines.
Regulatory and Safety Information
The BD 231673 - BD Sensi-Disc Cefpodoxime discs are intended for in vitro diagnostic use only and comply with all applicable FDA and CE regulatory standards. The discs are non-toxic and do not contain hazardous materials. A Safety Data Sheet (SDS) is available from BD upon request for detailed handling and storage information. Users should follow institutional biosafety and quality assurance protocols during testing to ensure accurate, reproducible, and compliant results.
How to Order
To order the BD 231673 - BD Sensi-Disc Cefpodoxime (10 mcg, Antimicrobial Susceptibility Discs), add the product to your cart and complete the checkout process. CIA Medical offers fast shipping, competitive pricing, and expert support for clinical and research laboratories. For bulk orders, technical documentation, or performance data, contact CIA Medicals customer service at (312) 275-5850 or submit an inquiry through the contact form on this page. Our specialists are available to assist with product specifications, availability, and ordering requirements.
